What is the level of liabilities of Cochlear this year?
Cochlear has a debt balance of 904.6 M AUD this year.
Cochlear Liabilities 2024
Cochlear Liabilities
904.6 M AUD
Ticker
COH.AX
ISIN
AU000000COH5
WKN
898321
In 2024, Cochlear's total liabilities amounted to 904.6 M AUD, a 16.06% difference from the 779.4 M AUD total liabilities in the previous year.
Cochlear Aktienanalyse
What does Cochlear do?
Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Cochlear's Liabilities
Cochlear's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Cochlear's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Cochlear's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Cochlear's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Cochlear’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Cochlear stock
What were the liabilities of Cochlear compared to the previous year?
The liabilities of Cochlear have increased by 16.06% increased compared to the previous year.
What are the consequences of high debt for investors of Cochlear?
High liabilities can pose a risk for investors of Cochlear, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Cochlear?
Low liabilities mean that Cochlear has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Cochlear affect the company?
An increase in liabilities of Cochlear can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Cochlear affect the company?
A decrease in the liabilities of Cochlear can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Cochlear?
Some factors that can influence the liabilities of Cochlear include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Cochlear so important for investors?
The liabilities of Cochlear are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Cochlear take to modify the liabilities?
To change its liabilities, Cochlear can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Cochlear pay?
Over the past 12 months, Cochlear paid a dividend of 5.42 AUD . This corresponds to a dividend yield of about 1.88 %. For the coming 12 months, Cochlear is expected to pay a dividend of 5.68 AUD.
What is the dividend yield of Cochlear?
The current dividend yield of Cochlear is 1.88 %.
When does Cochlear pay dividends?
Cochlear pays a quarterly dividend. This is distributed in the months of April, October, April, October.
How secure is the dividend of Cochlear?
Cochlear paid dividends every year for the past 26 years.
What is the dividend of Cochlear?
For the upcoming 12 months, dividends amounting to 5.68 AUD are expected. This corresponds to a dividend yield of 1.97 %.
In which sector is Cochlear located?
Cochlear is assigned to the 'Health' sector.
Wann musste ich die Aktien von Cochlear kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Cochlear from 10/10/2024 amounting to 2.82 AUD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Cochlear pay the last dividend?
The last dividend was paid out on 10/10/2024.
What was the dividend of Cochlear in the year 2023?
In the year 2023, Cochlear distributed 4.058 AUD as dividends.
In which currency does Cochlear pay out the dividend?
The dividends of Cochlear are distributed in AUD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Cochlear
Our stock analysis for Cochlear Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cochlear Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
